On this page:

• 2008
• 2009

2008

Alexander SI, Smith N, Hu M, Verran D, Shun A, Dorney S, Smith A, Webster B, Shaw PJ, Lammi A, Stormon MO. Chimerism and tolerance in a recipient of a deceased-donor liver transplant. New Engand Journal of Medicine. 2008; 358:369-374

Bell KJL, Irwig L, Craig JC, Macaskill P. Use of randomized trials to decide when to monitor response to new treatment. BMJ. 2008; 336: 361-365.

Hodson EM, Alexander SI. Evaluation and management of steroid sensitive nephrotic syndrome Current Opinion in Pediatrics. 2008;20: 145-150

Hodson EM, Craig JC. Therapies for steroid-resistant nephrotic syndrome. Pediatr Nephrol, 2008; 23(9): 1391-4 [published online 27 March 2008]

Hu M, Watson D, Zhang GY, Graf N, Wang YM, Sartor M, Howden B, Fletcher J, Alexander SI. Long-term Cardiac Allograft Survival Across a Major MHC Mismatch After "Pruning" of Alloreactive CD4 T Cells. J.Immunol. 2008 May 15;180(10):6593-6603.

Johnston O, Rose CL, Webster AC, Gill JS. Sirolimus is associated with new-onset diabetes in kidney transplant recipients. J Am Soc Nephrol 2008 Jul;19(7):1411-8.

Klassen TP, Hartling L, Craig JC, Offringa M. Children are not just small adults: The urgent need for high-qulaity trial evidence in children. PLoS Medicine 2008; 5(8):e172-

Morrow A, Quine S, Loughlin EVO, Craig JC. Different priorities: A comparison of parents' and health professionals' perceptions of quality of life in quadriplegic cerebral palsy. Archives of Disease in Childhood 2008; 93: 119-125. [published online first 11 Oct 2007]

Strippoli GFM, Navaneethan S, Johnson DM, Perkovic V, Pellegrini F, Nicolucci A, Craig JC. Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials BMJ 2008; 336(7645): 645-651. Editorials. Statins for people with kidney disease. BMJ, doi:10.1136/bmj.39483.665139.80

Tong A, Chapman S, Sainsbury P, Craig J. An analysis of media coverage on the prevention and early detection of chronic kidney disease in Australia. American Journal of Kidney Diseases 2008; 52(1): 159-170 [Epub 10 May 2008]

Tong A, Sainsbury P, Carter S, Hall B, Harris D, Walker R, Hawley C, Chadban S, Craig J. Patients' priorities for health research: focus group study of patients with chronic kidney disease. Nephrology Dialysis Transplantation 2008; 23: 3206-3214 [Epub 29 April 2008]

Tong A, Chapman S, Sainsbury P, Craig JC. What's the story on kidney disease? An analysis of media coverage on prevention and early detection of CKD in Australia. American Journal of Kidney Diseases 2008; 52: 159-170

Webster AC, Wong G, Craig JC, Chapman JR. Managing cancer risk and decision making after kidney transplantation. Am J Transplant 2008;8(11):2185-91.

Webster A, Wong G, Craig J, Chapman J. Managing cancer risk and decision making after kidney transplantation. American Journal of Transplantation 2008; 8(11): 2185-2191 [Epub 8 Sept 2008]


Williams G, Fletcher JT, Alexander SI, Craig JC. Vesicoureteric reflux. Journal of the American Society of Nephrology 2008; 19: 847-862, Epub ahead of print 5 Mar 2008


Wong G, Howard K, Craig JC, Chapman JR. Cost-effectiveness of colorectal cancer screening in renal transplant recipients. Transplantation 2008; 85(4): 532-541

Wang YM, Hu M, Wang Y, Polhill T, Zhang GY, Wang Y, Lee VW, Harris DC, Alexander SI. Regulatory T cells in renal disease. Int J Clin Exp Med. 2008;1(4):294-304. Epub 2008 Aug 20. PubMed PMID: 19079673; PubMed Central PMCID: PMC2596324.

2009

Albaramki JH, Teo J, Alexander SI. Rituximab therapy in two children with autoimmune thrombotic thrombocytopenic purpura. Pediatr Nephrol. 2009 Sep;24(9):1749-52. Epub 2009 Apr 28. PubMed PMID: 19399522.

Cross NB, Webster AC, Masson P, O'Connell PJ, Craig JC. Antihypertensives for kidney transplant recipients: systematic review and meta-analysis of randomized controlled trials Transplantation. 2009 Jul 15;88(1):7-18.

Fletcher JT, Nankivell BJ, Alexander SI. Chronic allograft nephropathy. Pediatr Nephrol. 2009 Aug;24(8):1465-71. Epub 2008 Jun 27. Review. PubMed PMID: 18584214; PubMed Central PMCID: PMC2697362.

Haysom L. Williams R. Hodson E. Lopez-Vargas P. Roy LP. Lyle D. Craig JC. Risk of CKD in Australian indigenous and nonindigenous children: a population-based cohort study. American Journal of Kidney Diseases. 53(2):229-37, 2009 Feb.

Haysom L, Williams R, Hodson E, Lopez-Vargas P, Roy LP, Lyle D, Craig JC. Natural history of chronic kidney disease in Australian Indigenous and non-Indigenous children: a 4 year population-based follow-up study. Medical Journal of Australia 2009; 190: 303-306

Irving M, McDonald S, Walker R, Frommer F, Craig J. Opinions on the content and effects of clinical practice guidelines for CKD: a survey of nephrologists in Australia and New Zealand. American Journal of Kidney Diseases. 2009 Jun;53(6):1082-90. [Epub 2009 Apr 25]

Orr N, McDonald S, McTaggart S, Henning P, Craig JC. Epidemiology of childhood end stage kidney disease in Australia and New Zealand. Accepted for publication in Pediatric Nephrology, March 2, 2009.

Strippoli GFM, Craig JC. Sunset for Statins after AURORA? Editorial in New England Journal of Medicine 2009; 306(14): 1455-1457

Sureshkumar P, Craig J, Jones M, Cumming B. A population-based study of 2856 children with urinary incontinence. Journal of Urology 2009; 181(2):808-815; discussion 815-6

Watson D, Hu M, Zhang GY, Wang YM, Alexander SI. Tolerance induction by removal of alloreactive T cells: in-vivo and pruning strategies. Curr Opin Organ Transplant. 2009 Aug;14(4):357-63. PubMed PMID: 19610169.

Watson D, Zheng G, Wu H, Wang YM, Wang Y, Harris DC, [[b||Alexander SI. CCL2 DNA vaccine to treat renal disease. Int J Biochem Cell Biol. 2009 Apr;41(4):729-32. Epub 2008 Aug 13. PubMed PMID: 18768165.

Zhang GY, Hu M, Wang YM, Alexander SI. Foxp3 as a marker of tolerance induction versus rejection. Curr Opin Organ Transplant. 2009 Feb;14(1):40-5. Review. PubMed PMID: 19337145.